Large-scale testing (Phase 3)Study completedNCT02178956
What this trial is testing
BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer
Who this might be right for
Gastric CancerGastroesophageal Junction Cancer
Sumitomo Pharma America, Inc. 714